Differences in Creatinine and Ureum Levels 2nd Month and 3rd Month in Tuberculosis Patients of OAT Therapy
DOI:
https://doi.org/10.59890/ijels.v2i7.2405Keywords:
Tuberculosis Drugs, 2nd Month, 3nd Month, Creatinine, UreumAbstract
Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis. Tuberculosis patients who test positive must undergo therapy using Anti-Tuberculosis Drugs (OAT). Treatment is divided into two phases, namely the intensive phase is carried out for 2 months with the consumption of rifampicin (R), isoniazid (H), pyrazinamide (Z), and etambutol (E) and the advanced phase is carried out for 4 months with isoniazid (H) and rifampicin (R) OAT. To find out the difference in creatinine and urea levels in the 2nd and 3rd months. Typeof research using quantitative with aprospective cohort research design. The sampling technique uses the purposive sampling method with a sample number of 15. Normality and homogeneity tests were carried out,normal distributed results were obtained and the number of samples did not meet the requirements, so the Wilcoxon statistical test was used. A total of 12 respondents (80.0%) experienced a decrease in urea levels from the 2nd month to the 3rd month. There was a differencein creatinine levels at the 2nd and 3rd months with a p-value of 0.026 (p < 0.05), butthere was no difference inthe urea levelsat the 2nd and 3rd months with a p-value of 0.201 (p < 0.05).References
Aminah, S. (2013). Differences in SGOT, SGPT, Urea, and Creatinine Levels in TB Patients. Journal of Health Analysts, 2(2), 260–269.
Anggraeni Novitasari, P., Kahar, F., & Irnawati. (2022). Overview of the Positivity of Acid-Resistant Bacilli in Patients with Clinical Diagnosis of Pulmonary Tuberculosis at the Semarang Public Health Center. Journal of Medical Laboratories , 4(2), 95–100. https://ejournal.poltekkes-smg.ac.id/ojs/index.php/JLM/
Aprianto, A., Sudarsono, T. A., Kusuma Wardani, D. P., & Rahaju, M. (2022). Comparison of Ureum and Creatinine Levels in Patients with Pulmonary Tuberculosis in the Treatment Phase 0 and 6 Months. Jurnal Ilmu Dan Teknologi Kesehatan, 10(1), 14–24. https://doi.org/10.32668/jitek.v10i1.927
Chang, C. H., Chen, Y. F., Wu, V. C., Shu, C. C., Lee, C. H., Wang, J. Y., Lee, L. N., & Yu, C. J. (2014). Acute kidney injury due to anti-tuberculosis drugs: A five-year experience in an aging population. BMC Infectious Diseases, 14(1). https://doi.org/10.1186/1471-2334-14-23
Denrison, P., & Erdiana, G. (2020). Analysis of blood creatinine levels in patients with pulmonary tuberculosis who have been consuming anti-tuberculosis drugs for more than 4 months at the Medan Community Lung Health Unit. Medical Laboratory Analyst, 4, No 2. http://e-journal.sari-mutiara.ac.id
Dhanny, D. R., & Sefriantina, S. (2022). The Relationship between Energy Intake, Protein Intake and Nutritional Status to the Incidence of Tuberculosis in Children. Muhammadiyah Journal of Nutrition and Food Science (MJNF), 2(2), 58. https://doi.org/10.24853/mjnf.2.2.58-68
Djasang, S., & Saturiski, M. (2019). Study on the Results of Urea and Uric Acid Examination in Patients With Pulmonary Tuberculosis Taking Intensive Anti-Tuberculosis (OAT) Drugs. Journal of Health Analyst Media, 10(1), 1–7. https://doi.org/https://doi.org/10.32382/mak.v10i1.985
Erlitania S, Y. (2018). Effect of Rifampicin and Dexamethasone Administration on Abnormalities in Kidney Function and Structure of Rats. Inpatient Dermatology, 169–174. https://doi.org/10.1007/978-3-319-18449-4_35
Fortuna, T. A., Rachmawati, H., Hasmono, D., & Karuniawati, H. (2022). Study on the Use of Advanced Anti-Tuberculosis Drugs (OAT) in New Patients Positive BTA. Pharmacon: Indonesian Journal of Pharmacy, 19(1), 62–71. https://doi.org/10.23917/pharmacon.v19i1.17907
Harison, M. F. (2019). Overview of urea and creatinine levels in patients with pulmonary tuberculosis who received anti-tubulous drug therapy (OAT) at the hospital. Especially for the lungs of South Sumatra Province in 2019.
Herman, J., Wahyunie, S., & Kusumawati, N. (2024). Overview of creatinine levels in pulmonary tuberculosis patients with oat treatment category 1. Journal of Medika Malahayati, 7(4), 1042–1049. https://doi.org/10.33024/jmm.v7i4.11839
Indriani, V., Siswandari, W., & Lestari, T. (2017). The Relationship between Urea, Creatinine and Creatinine Clearance Levels with Proteinuria in Diabetic Mellitus Patients. Proceedings of the National Seminar on Rural Resource Development and Sustainable Local Wisdom VII 17-18, 1(November), 758–765.
http://www.jurnal.lppm.unsoed.ac.id/ojs/index.php/Prosiding/article/viewFile/524/435
Kahar, F., Irnawati, M., Yusuf, R., Salam, A., & Wadood, A. (2023). Public Knowledge About Pulmonary Tuberculosis (TB): a Cross-Sectional Study in Indonesia. International Journal of Education and Life Sciences (IJELS), 1(2), 81–94. https://www.researchgate.net/profile/Abdul-Salam-22/publication/374997803_Public_Knowledge_About_Pulmonary_Tuberculosis_Tb_a_Cross-_Sectional_Study_in_Indonesia/links/653a67011d6e8a7070506895/Public-Knowledge-About-Pulmonary-Tuberculosis-Tb-a-Cross-Sectio
Kahar, F., Purlinda, D. E., & Setyowatiningsih, L. (2022). Profile of Diabetes Mellitus in Tuberculosis Patients. Proceedings of the UNIMUS National Seminar, 5, 1086–1095.
Kahar, F., Sugihantono, A., Yusuf, M., & Wikandari, R. J. (2023). Community empowerment through assistance in the Health Promotion Model (HPM) program and correct sneeze ethics training as an effort to prevent tuberculosis (TB) cases. Proceedings of the UNIMUS National Seminar, 6, 1298–1312.
Kahar, F., Widarti, & Wikandari, R. J. (2022). Respondent Characteristics and Student Health Knowledge About Covid-19. Journal for ReAttach Therapy and Developmental Diversities, 5(1), 28–40.
Kahar, F., Salam,A & Wadodo, A ,et all (2022). Tuberculosis and Chronic Kidney Diseas : Study in Patients on Anti-Tuberculosis Drug Therapy : A Sistematic Review. Proceedings International Conference on Handling Non-Communicable Diseases “Improving Kidney Health for Handling Non Communicable Diseases in Health Transformation Era”,Semarang , 614–625.
Ministry of Health of the Republic of Indonesia. (2016). Regulation of the Minister of Health of the Republic of Indonesia Number 67 of 2016. 163.
Maulana, L. Y. (2021). The Relationship Between Tuberculosis Antu Drug (OAT) Administration and Urea and Cratinine Levels in Pulmonary TB Patients (Literature Study). Tanjungkarang Health Polytechnic.
Nisak, Z., Dyah, Y., & Santik, P. (2021). Incidence of Tuberculosis: A Case Study in the Working Area of the Health Center. Ijphn, 1(3), 783–792. http://journal.unnes.ac.id/sju/index.php/IJPHN
Nursidika, P., Furqon, A., Hanifah, F., & Anggarini, D. R. (2017). Description of Abnormalities of the Patient's Liver and Kidneys. Kartika Health Journal, 12(1), 1–12.
Pratiwi, R. M., & Suryanto. (2017). DIFFERENCES IN UREA-CREATININE LEVELS BEFORE AND AFTER ADMINISTRATION OF EARLY-PHASE ANTITUBERCULOSIS DRUGS. 2010, 3–7.
Pratiwi, R., & Suryanto. (2019). Differences in urea-creatinine levels before and after administration of early-phase antituberculosis drugs. Yogyakarta, 000, 3–7. https://adoc.pub/download/perbedaan-kadar-ureum-kreatinin-sebelum-dan-sesudah-pemberia.html
Purba, S. K. R. (2019). Analysis of Urea Levels in the Serum of Pulmonary TB Patients Taking Anti-Tuberculosis Drugs for More Than 4 Months at Prodia Duri Laboratory. The Indonesian Journal of Medical Laboratory, 1(1), 1–4. http://114.7.97.203:8123/inlislite3/uploaded_files/dokumen_isi/Monograf/12034119_001.pdf
Rahman, A. T., D-III Health Analyst, P., Public Health, F., & East Indonesia Jl Abdul Kadir No, U. (2020). The Effect of Drug Consumption Time in TB Patients on Creatine and Urea Levels in the Laboratory of UIT Makassar Hospital 2018. Journal of Media LAboran , Vol 10. No(November), 48–52.
Risma, & T, A. R. (2020). The Effect of Drug Consumption Time in TB Patients with Creatine and Urea Levels in the Laboratory of UIT Makassar Hospital 2018. Journal of Laboratory Media, 10(2), 1–7.
Ristanti, E. (2020). Analysis of factors influencing the incidence of pulmonary tuberculosis. 32.
Singh, N., Ganguli, A., & Prakash, A. (2003). Drug-induced kidney diseases. J Assoc Physicians India, 5, 970–979. https://pubmed.ncbi.nlm.nih.gov/
Suryawan, D. G. A., Arjani, I. A. M. S., & Sudarmanto, I. G. (2017). Overview of serum urea and creatinine levels in chronic kidney failure patients undergoing hemodialysis therapy at Sanjiwani Gianyar Hospital. Meditory: The Journal of Medical Laboratory, 4(2), 145–153. https://doi.org/https://doi.org/10.33992/m.v4i2.64
WHO. (2022). Global Tuberculosis Report 2022. https://www.who.int/teams/global-tuberculosis-programme/tb-reports
Wibowo, W., Mulia, Y. S., Sunarno, S., Su'udi, A., Putranto, R. H., Kusumawati, K., & Renitia, G. I. (2023). Analysis of urea, creatinine, and uric acid levels in oat-pulmonary tuberculosis. Journal of Health Research of the Ministry of Health of Bandung, 15(2), 442–449. https://doi.org/10.34011/juriskesbdg.v15i2.2222
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Azizah Krissan Zahra, Fitriani Kahar, Nurul Qomariyah, Anung Sugihantono, Yusriyanto, Irnawati
This work is licensed under a Creative Commons Attribution 4.0 International License.
